Domestic medical equipment accelerates import substitution for three types of stocks, enjoying policy red envelopes

Recently, the National Health and Family Planning Commission announced that in order to promote the development and application of domestic medical equipment, promote the transformation and upgrading of related industries, drive economic growth, and reduce medical costs, the Planning Department of the National Health and Family Planning Commission has entrusted the China Medical Equipment Association to launch the selection of domestic medical equipment products. Taking into account factors such as domestic equipment production capacity, market development space, and product utilization, three basic medical equipment items were selected for selection: digital X-ray machines, color Doppler ultrasound diagnostic instruments, and fully automatic biochemical analyzers. According to the work arrangement, timely carry out the selection of other items.

Encouraged by this, medical device stocks have been relatively active recently, with 11 stocks experiencing a counter trend rise in stock prices since June (the Shanghai Composite Index fell 0.43% during the same period), accounting for 57.89%. Among them, Qianshan Pharmaceutical Machinery ranked first with a cumulative increase of 7.92% during the period, while individual stocks such as Guanhao Biotechnology (5.26%), Jiu'an Medical (4.73%), Yangpu Medical (4.53%), Libang Instrument (3.09%), Baolaite (1.96%), and Yuyue Medical (1.84%) all had a cumulative increase of over 1% during the period.

In terms of fund flow, since June, a total of 6 concept stocks in the sector have achieved net inflow of large orders of funds, with a cumulative inflow of 92.2786 million yuan. Among them, the net inflow of large order funds from Libang Instrument ranked first, reaching 38.522 million yuan. During the period, the cumulative net inflow of large order funds from two concept stocks, Jiu'an Medical and Shangrong Medical, also exceeded 10 million yuan, with 24.2951 million yuan and 18.2111 million yuan respectively. In addition, individual stocks such as Yuyue Medical (6.9849 million yuan), Guanhao Biotechnology (3.469 million yuan), and Baolaite (7.964 million yuan) also received favor from large order funds during this period.

According to official documents, the selection process was organized by the Information Department of the National Health and Family Planning Commission, and the China Medical Equipment Association was responsible for the selection. The above three varieties will be selected in the first half of this year, and the selection of other varieties will begin in the second half, including medical equipment, instruments, and consumables, providing reference for hospitals to equip medical equipment in the future. This selection may completely change the situation where foreign brands dominate the domestic medical device industry, and due to the fact that basic parameters such as enterprise size account for 20% of the selection criteria, it will be more favorable for large domestic enterprises.

Source: 3618 Medical Device Network